戻る
Ascentage Pharma Group International (6855.HK)価格
6855.HK 株価推移チャート
ASCENTAGE-B (6855.HK)
Ascentage Pharma Group International
HK$49.48
-0.44%
$-0.22
休場: Jan 28, 16:00:00 HKT
主要データ
前終値
$49.44
始値
$49.7
当日レンジ
$48.96 - $50.2
52週レンジ
$31.35 - $95.35
取引高
1.0M
平均取引高
1.9M
1株当たり利益(TTM)
-4.01
配当利回り
--
時価総額
$18.3B
ASCENTAGE-Bとは何ですか？
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
